Skip to main content

Advertisement

SpringerLink
Log in

Empfehlungen zum Einsatz von Abatacept bei Patienten mit rheumatoider Arthritis

  • Qualitätssicherung
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Manger B, Michels H, Nüsslein H et al. (2006) und die Kommission Pharmakotherapie der DGRh. Neufassung der Empfehlungen der DGRh zur Therapie mit Tumornekrosefaktor-hemmenden Wirkstoffen bei entzündlich-rheumatischen Erkrankungen (Stand März 2006). Z Rheumatol 66: 72–75

    Google Scholar 

  2. Rubbert A, Burmester G (2008) und die Kommission Pharmakotherapie der DGRh. Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis. Z Rheumatol 68 (im Druck)

  3. Furst DE, Breedveld FC, Kalden JR et al. (2007) Updated consensus statement on biological agents for the treatment of rheumatic diseases 2007. Ann Rheum Dis 66 Suppl III: iii2–iii22

    Article  Google Scholar 

  4. Kremer JM, Genant HK, Moreland LW et al. (2006) Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med 144: 865–876

    PubMed  CAS  Google Scholar 

  5. Genovese MC, Becker JC, Schiff M et al. (2005) Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 353: 1114–1123

    Article  PubMed  CAS  Google Scholar 

  6. Moreland LW, Alten R, van den Bosch F et al. (2002) Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum 46: 1470–1479

    Article  PubMed  CAS  Google Scholar 

  7. Kremer JM, Dougados M, Emery P et al. (2005) Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept. Arthritis Rheum 52: 2263–2271

    Article  PubMed  CAS  Google Scholar 

  8. Weinblatt M, Combe B, Covucci A et al. (2006) Safety of the selective co-stimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and non-biologic DMARDs: a 1 year randomised study. Arthritis Rheum 54: 2807–2816

    Article  PubMed  CAS  Google Scholar 

  9. Weinblatt M, Schiff M, Goldman A et al. (2007) Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial. Ann Rheum Dis 66: 228–234

    Article  PubMed  CAS  Google Scholar 

  10. Schiff M, Keiserman M, Codding C et al. (2007) Efficacy and safety of abatacept or infliximab versus placebo in ATTEST: a Phase III, multicenter, randomized, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis published online 29 Nov 2007

  11. Salliot C, Dougados M, Gossec L (2008) Risk of serious infections during rituximab, abatacept and anakinra therapies for rheumatoid arthritis: meta-analyses of randomized placebo-controlled trials. Ann Rheum Dis [published online 18 Jan 2008]

  12. Haggerty HG, Abbott MA, Reilly TP et al. (2007) Evaluation of immunogenicity of the t cell costimulation modulator iabatacept in patients treated for rheumatoid arthritis. J Rheumatol 34: 2365–2373

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Praxiszentrum St. Bonifatius, München, St.-Bonifatius-Str. 5, 81541, München, Deutschland

    K. Krüger

  2. Universitätsklinikum Münster, Münster, Deutschland

    M. Gaubitz

Authors
  1. K. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gaubitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Kommission Pharmakotherapie der DGRh

Corresponding author

Correspondence to K. Krüger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, K., Gaubitz, M. & Kommission Pharmakotherapie der DGRh. Empfehlungen zum Einsatz von Abatacept bei Patienten mit rheumatoider Arthritis. Z. Rheumatol. 67, 614–616 (2008). https://doi.org/10.1007/s00393-008-0347-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-008-0347-9

Search

Navigation